Chimerix Inc (CMRX)
3.34
+0.32
(+10.60%)
USD |
NASDAQ |
Dec 24, 16:00
Chimerix Cash from Investing (Quarterly): 28.32M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cumberland Pharmaceuticals Inc | 0.1896M |
| Abbott Laboratories | -594.00M |
| Emergent BioSolutions Inc | 112.00M |
| Tonix Pharmaceuticals Holding Corp | -0.009M |
| Geovax Labs Inc | -0.0207M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.51M |
| Cash from Financing (Quarterly) | 0.178M |
| Free Cash Flow | -70.42M |
| Free Cash Flow Per Share (Quarterly) | -0.2289 |
| Free Cash Flow to Equity (Quarterly) | -20.53M |
| Free Cash Flow Yield | -23.59% |